Researchers have made progress against ‘the skull challenge,’ getting through barriers that prohibit ultrasound from imaging ...

Nuclidium’s radiopharmaceutical platform is unique in its use of copper-based payloads, which the biotech claims can deliver higher doses while also being safer.

A scan that can detect Alzheimer’s disease before memory loss begins is now available in the UAE for the first time. The amyloid PET scan, recently launched at Cleveland Clinic Abu Dhabi, is a ...

A cutting-edge brain imaging platform that integrates upright PET scanning, an augmented reality (AR) headset, and motion ...

New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed Amyloid, a naturally occurring protein, can accumulate ...

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, ...

This new study takes a deeper look at how some of those modifiable risks actually affect Alzheimer’s disease at a biological ...

Global Medical Image Analysis Software Market Size Set to Cross USD 5.62 Billion by 2029 Global medical image analysis software market is flourishing due to the increasing use of ultrasonic imaging ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

A novel PET imaging study has identified unique patterns of neuroinflammation in patients with progressive apraxia of speech (PAOS), a rare disorder that impairs the brain’s ability to plan speech.

PDE-1905, offers high-resolution imaging of neuroinflammation by targeting a key enzyme inside microglia, the brain’s immune cells.